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Abstract. Individuals have different preferences in how they wish to relate to 
healthcare professionals such as doctors. Given choice, they also have preferences 
in relation to the type and location of support they want for their health and 
healthcare decisions. We argue that preference-based clusters within this 
heterogeneity constitute different contexts and that evaluations of decision aids 
should be context-sensitive in this respect. We draw attention to two distinct 
preference-based clusters: individuals with a preference for ‘intermediative’ 
decision support as a patient, implemented in a largely qualitative deliberative 
model, on the one hand, and for ‘apomediative’ decision support as a person, 
implemented in a largely quantitative multi-criteria decision analytic model, on the 
other. For convenience, we refer to the latter as Person Decision Support Tools 
(PDSTs), leaving Patient Decision Aids (PDAs) for its former, conventional use. 
Seeking to establish proof of method, we present an online PDST that can help 
individuals establish which of these two types of decision support they would find 
optimal. It is based on nine key attributes on which PDAs and PDSTs can be 
contrasted. Within population heterogeneity, preference clusters should be 
identified, and acknowledged and respected as contexts relevant to the evaluation 
of decision support tools. 
Keywords. Patient decision aid, person decision support tool, decision quality, 
apomediation, intermediation, shared decision making, preferences 
1. Introduction 
In a much-needed reminder that shared decision making is a means to an end, not an end 
in itself, Barry and co-authors argue that the ultimate product of a shared decision making 
process - indeed of any decision making process - is the decision [1]. The primary 
outcome in the evaluation of any decision-making process, perhaps especially a decision-
aided one, should therefore be the quality of that decision. It is somewhat surprising, 
then, that the latest systematic review concluded that, while patient decision aids used in 
clinical encounters significantly increased patients’ knowledge, lowered decisional 
conflict, increased observation-based assessment of shared decision making, and 
satisfaction with the decision-making process, decision quality was not mentioned as an 
outcome anywhere in the research covered [2]. Among the possible explanations, we 
suggest here that it is because decision quality, as a formative construct, requires 
measurement which is both context- and preference-sensitive. It follows that both types 
of sensitivity are needed in evaluating any decision making process (including shared 
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decision making), in evaluating any decision aids designed to support decision making 
(whether ‘shared’ or not), and in evaluating any instrument proposed to evaluate either.  
The vast majority of health decisions taken by individuals are preference-sensitive. 
Multiple considerations – various benefits and harms - are relevant and decisions require 
the relative importance of each to be established, indicating the trade-offs they are willing 
to make among them. Any decision aid needs to recognise and reflect the multi-criterial 
and preference-sensitive nature of health decisions. In the context of person-centred 
health decisions the relevant preferences are those of the individual person (patient-as-
person, not as patient) elicited at the point of care [3]. The individual’s preferences 
cannot be treated as just further epidemiological characteristics, to be added to their age, 
sex, location, or literacy level [4]. This ontological transgression is committed in any 
clinical or clinical guideline context when the person’s preferences are regarded as 
adequately captured by the dependent variable in a group-based regression equation 
which employs their epidemiological characteristics as the independent variables.  
This offence can, however, only occur in the clinical setting. Elicitation and use of 
average group preferences is valid and necessary in policy development and decision 
making. Here the key issue becomes the appropriate level of aggregation and hence the 
appropriate context for analysis and evaluation. It is clear from clustering studies that 
preference-based sub-groups exist in most populations in relation to many, if not most, 
health-related conditions. As just one example, in the case of PSA screening for Prostate 
Cancer, preference-based sub-groups are constituted by the different relative importance 
attached to avoiding prostate cancer on the one hand and experiencing the impotence and 
incontinence side effects of treatment on the other [5]. In this paper we argue that a 
preference cluster constitutes a context and that evaluations of decision aids and decision 
quality should be sensitive to preference-defined contexts.  
Preferences may relate to states, as in the PSA screening case, or to processes. Here 
we pursue the notion of preference-based contextualisation in the provision of decision 
support processes that can potentially enhance decision quality. If there is surprise that 
cognition-based contexts are being proposed, it is worth pointing out that 
contextualisation on the basis of cognitive pathology is well accepted in mental health. 
And, beyond health, segmentation on the basis of the preferences of consumers – in most 
cases assumed to be in ‘normal’ health – is the accepted basis of marketing success.  
2. Preference-Based Contexts for Decision Support 
As stated at the outset, a vital contribution made by the Barry piece is in pointing to the 
context-sensitivity of the definition and measurement of shared decision making. They 
note that the National Quality Forum definition does not specify how or where it might 
take place and that patients and clinicians interact in many ways - phone conversations, 
virtual visits, email, and web portals are all ways of communicating about a decision.  
Furthermore, they acknowledge that personal preferences will affect not only the 
type and location of shared decision making, but whether it occurs. Crucially for this 
paper they draw attention to their earlier study [6] in which it was found that 38% of men 
given a decision aid on PSA screening for prostate cancer outside a visit wanted to make 
the decision themselves before viewing it. This figure rose to 43% after viewing the aid. 
‘In the face of such strong data, should we still require these men to come in for an 
additional face-to-face visit to say that shared decision-making happened?’ ask the 
authors. Finally, they note that the Cochrane review showed that the use of patient 
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decision aids is linked to improvements in ‘decision quality’ in the domains we have 
discussed, including knowledge, involvement, and match between values and choices, 
without apparent harms [7]. ‘These benefits were seen regardless of whether the patient 
decision aids were used within or outside of clinician visits.’ 
It is clear from this, and many other studies (including on internet searching), that 
individuals have heterogeneous preferences in relation to the way they wish to relate to 
health professionals (especially doctors); also, that given choice, they have preferences 
in relation to the type and location of support they prefer for their health decisions. At 
the moment they have limited choice, especially where only licenced practitioners can 
perform some actions (diagnose conditions, prescribe many medications). But the scope 
for autonomous choice is expanding rapidly as the digital paradigm envisaged by 
futurists such as Eric Topol [8], Robin Farmfarmanian [9], and Bertalan Mesko and Dave 
deBronkart [10], encroaches on the status quo. In the not too distant future self-
production of health is supplemented by its co-creation undertaken in collaboration with 
a healthcare professional; a process akin to ‘shared decision making’ but only when the 
empowered person is the driver [11]. 
The mainstream orthodoxy in relation to decision support for individual’s health 
decisions focuses on just one context, that of Shared Decision Making (SDM) between 
clinician (or clinical team) and patient. This SDM can be facilitated by Patient Decision 
Aids such as Option Grids [12], assessed normatively by IPDASi standards [13]. The 
extent to which the SDM occurs in deliberative consultations is to be measured by 
instruments such as OPTION [14]. Empirical implementations of the PDAs are to be 
evaluated by DQIs [15]. (We cite only Dartmouth-Boston examples; others exist.) 
To make clear the existence of at least one other major context, we draw attention 
to two distinct preference-based clusters in the population: individuals with a preference 
for intermediative decision support as a patient, implemented in a largely qualitative 
deliberative model on the one hand, and for apomediative decision support as a person, 
implemented in a largely quantitative multi-criteria decision analytic model on the other. 
For convenience we will refer to the latter as Person Decision Support Tools (PDSTs), 
leaving Patient Decision Aids (PDAs) for its former, conventional, use.  
Following Eysenbach [16] decision support is ‘apomediative,’ when the resources 
involved are produced independently of the provider of the good or service in question 
(apo = away from) and are delivered publicly accessible ‘direct to person’ in the 
community. Familiar examples of apomediative decision support resources, based on 
largely quantitative multi-criteria decision analytic models, are the proliferating product 
and service comparison websites, such as ‘Which’ in the UK, ‘Consumer Reports’ in the 
US, and ‘Taenk’ in Denmark. Apomediation is distinguished from ‘intermediation,’ 
where the provider develops a decision support resource on the basis of their perceptions 
and decisions as to what the patient can benefit from, as well as their in/ability to deliver 
options that could potentially be covered in the resource. Intermediation is not provider-
independent and options present in an apomediative aid may be censored or filtered on 
the basis of the beliefs, values, and interests of providers – and any other stakeholders 
involved in intermediative aid development. Public access PDSTs which constitute the 
main type of apomediative resource, eschew such option censoring or filtering, seeking 
to supply high quality independent guidance without conflicts of interest of any sort.  
Apomediation is to be distinguished from ‘dis-intermediation,’ where the individual 
(sometimes a dissatisfied patient) attempts to find what they want without help from 
healthcare providers, for example by doing anonymous internet searches. Apomediation 
can therefore be seen as acknowledging some of the motivations underlying dis-
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intermediation but seeking to supply a better alternative to Dr Google - one which will 
be superior, or inferior, to intermediation depending on the preferences of the person. 
If engagement with an apomediative aid results in a decision to contact a healthcare 
professional, we have the possibility of blended ‘apo-intermediation’. However, in this 
case the clinician will engage with the person in a way that is different from that which 
characterises the pure intermediative mode. For example, they will need to be prepared 
to discuss options in the apomediative PDST that may not have appeared in an 
intermediative PDA for the same decision. 
Even if an intermediative aid is made available online at home as preparation for an 
encounter - as in the Barry PSA study - it remains an intermediative PDA. It will be 
recalled that 43% of their participants decided to treat it as apomediative support, so the 
issue is whether those who prefer to decide for themselves would not be better served by 
a genuine apomediative aid, one which will have different characteristics and require 
different standards and evaluation.  
3. Establishing Preference-Based Contexts 
Information support is only a component of decision support. Decision support requires 
showing how any information can be incorporated into a decision framework that also 
introduces the preference component and makes the impact of each component 
observable and explorable. It is characteristic of intermediative decision aids that they 
are not based on any analytic model and aim to help the patient ‘make up their mind’ 
during shared encounter deliberation, without producing a preliminary opinion to be 
discussed. In contrast, to be effective in their community setting, apomediative resources 
must include decision support, not just information support. 
Seeking to establish proof of method, we present an online PDST that can help 
individuals establish which of the two types of decision support they would find optimal, 
based on their preferences over the key distinguishing attributes. Nine attributes which 
distinguish PDAs from PDSTs (as defined) were derived from surveying a large number 
of the PDAs in the Ottawa Directory (https://decisionaid.ohri.ca/AZlist.html), as well as 
the IPDASi checklist for PDAs [13] and a tabular comparison of the latter with the 
contents of an MCDA-based PDST. [17] (Table 2, p.6). These attributes exclude those 
associated with development processes, or supplementary information presentation 
concerning condition or options, where both types are assumed to meet equally well. Full 
definitions are in the online tool at https://ale.rsyd.dk (enter 1498 as survey ID).  
Shorthand versions of the nine criteria are:  
 Home vs clinic engagement. 
 No option filtering vs option filtering. 
 Do nothing option included vs only action options. 
 Numerical vs verbal chances. 
 Absolute vs relative risks. 
 Overall vs only condition-specific mortality/morbidity. 
 Functional vs clinical outcomes. 
 Numerical vs verbal preference weights. 
 Calculated option scores vs no opinion.  
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Figure 1. Screen capture from online tool with purely illustrative responses. 
Slight stereotyping of PDAs is involved as a few will not match all these 
characteristics. 
Results from this survey will establish the number and strength of the emergent 
preference clusters, but their existence is not in serious doubt. Even a small number 
preferring PDSTs will justify their production and delivery, subject to cost-effectiveness 
considerations. In this respect, any relevant cost-effectiveness analysis must cover the 
production and delivery processes for both types, as well as their service consequences. 
In many cases, especially screening, PDSTs are likely to be cost-effective, possibly even 
cost saving, as a result of reducing preference-based over-diagnosis and over-treatment. 
4. Conclusion 
The preferences of individuals in relation to health and healthcare decision making 
processes are heterogeneous. Within this heterogeneity preference clusters should be 
identified and acknowledged and respected as contexts relevant to the evaluation of 
decision support tools. The task of developing normative and empirical evaluation tools 
for the full range of preference-based contexts, including apomediation, remains. 
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